Ross E. Rocklin

Ross E. Rocklin's AcademicInfluence.com Rankings

Ross E. Rocklin

Philosophy

#8115

World Rank

#11438

Historical Rank

Logic

#5146

World Rank

#6520

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ross E. Rocklin's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Ross E. Rocklin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ross E. Rocklin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. (2014) (1041)
Dupilumab in persistent asthma with elevated eosinophil levels. (2013) (667)
Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. (1990) (567)
Generation of antigen-specific suppressor cells during allergy desensitization. (1980) (288)
Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. (1976) (281)
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. (1976) (263)
An in vitro assay for cellular hypersensitivity in man. (1970) (252)
Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). (1974) (228)
STUDIES ON MEDIATOR PRODUCTION BY HIGHLY PURIFIED HUMAN T AND B LYMPHOCYTES (1974) (220)
Cellular sensitivity to collagen in rheumatoid arthritis. (1978) (186)
Mediators of immunity: lymphokines and monokines. (1980) (155)
The influence of histamine on immune and inflammatory responses. (1984) (146)
Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation. (1977) (144)
The effect of immunotherapy on humoral and cellular responses in ragweed hayfever. (1976) (143)
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. (1971) (143)
Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF). (1980) (137)
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. (1970) (125)
Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. (1972) (118)
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. (1970) (100)
Production of migration inhibitory factor by non-dividing lymphocytes. (1973) (99)
Maternal-fetal relation. II. Further characterization of an immunologic blocking factor that develops during pregnancy. (1982) (97)
Immunobiology of the maternal-fetal relationship. (1979) (97)
Abnormal histamine-induced suppressor-cell function in atopic subjects. (1982) (97)
Modulation of cellular immune function in vitro by histamine receptor-bearing lymphocytes: mechanism of action. (1978) (95)
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. (1972) (92)
Role of monosaccharides in the interaction of two lymphocyte mediators with their target cells. (1976) (86)
Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. (1979) (83)
Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. (1987) (79)
Histamine-induced suppressor-cell activity. (1984) (79)
Autacoids as modulators of the inflammatory and immune response. (1981) (78)
Immunologic components of hypersensitivity reactions to cromolyn sodium. (1975) (71)
THE COMPARTMENTALIZATION OF ANTIGEN-REACTIVE LYMPHOCYTES IN DESENSITIZED GUINEA PIGS (1971) (68)
Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A). (1975) (67)
Transfer factor therapy in a patient with progressive primary tuberculosis. (1973) (63)
Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E. In vitro lymphocyte transformation and elaboration of lymphocyte mediators. (1974) (63)
Activation of human blood monocytes by products of sensitized lymphocytes. (1974) (60)
Suppression of maternal responsiveness to paternal antigen by maternal plasma. (1975) (60)
Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma. (1983) (58)
Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy. (2011) (57)
Histamine modulates in vitro IgG production by pokeweed mitogen-stimulated human mononuclear cells. (1981) (52)
Histamine-induced suppressor factor (HSF): inhibition of helper T cell generation and function. (1983) (51)
Functional features of lymphocytes recovered from a human renal allograft. (1973) (50)
IgE production in vitro by human blood mononuclear cells: a comparison between atopic and nonatopic subjects. (1983) (49)
Histamine type I (H1) receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. (1986) (49)
Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni. (1980) (48)
In vitro lymphocyte response of patients with immunologic deficiency diseases. (1970) (47)
Evidence that human leukocyte inhibitory factor (LIF) is an esterase. (1976) (47)
Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. (1975) (45)
Cellular interactions in the generation and expression of histamine-induced suppressor activity. (1982) (45)
T cell responses in allergic rhinitis, asthma and atopic dermatitis (1989) (45)
RAPID DESENSITISATION FOR DESFERRIOXAMINE ANAPHYLACTIC REACTION (1981) (45)
The effect of purified α-fetoprotein on in vitro assays of cell-mediated immunity (1977) (41)
Characterization of the neutrophil respiratory burst in atopy. (1988) (41)
Detection in vitro of cellular hypersensitivity to drugs. (1971) (40)
Nasal eosinophilia in allergic and nonallergic rhinitis: usefulness of the nasal smear in the diagnosis of allergic rhinitis. (1989) (39)
Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. (1988) (39)
Effect of Vitamin E Supplementation on Immune Responsiveness of the Aged a (1989) (38)
Phenotypic and functional evaluation of suppressor cells in normal pregnancy and in chronic aborters. (1986) (37)
Asthmatic patients have neutrophils that exhibit diminished responsiveness to adenosine. (1989) (36)
Reduced production of histamine-induced suppressor factor (HSF) by atopic mononuclear cells and decreased prostaglandin E2 output by HSF-stimulated atopic monocytes. (1983) (36)
Activation of antigen-specific suppressor cells in human schistosomiasis mansoni by fractions of soluble egg antigens nonadherent to Con A sepharose. (1981) (35)
Human monocyte-derived soluble product(s) has an accessory function in the generation of histamine- and concanavalin A-induced suppressor T cells. (1982) (35)
Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency. (1972) (34)
Pleuropericardial reaction to treatment with dantrolene. (1979) (34)
Altered arachidonic acid metabolism and platelet size in atopic subjects. (1988) (30)
Immunosuppressive characteristics of human AFP: effect on tests of cell mediated immunity and induction of human suppressor cells. (1978) (29)
Histamine modulation of lymphocyte biology: membrane receptors, signal transduction, and functions. (1987) (27)
Pernicous anaemia, hypogammaglobulinaemia, and altered lymphocyte reactivity. A family study. (1972) (26)
Cellular immune responses in familial medullary thyroid carcinoma. (1977) (25)
Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF). (1983) (23)
Physiochemical characterization of human histamine-induced suppressor factor. (1983) (23)
Migration inhibitory factor (MIF) and proliferative responses by human lymphocyte subpopulations separated by sheep erythrocyte rosette formation. (1976) (22)
Transfer factor treatment of chronic mucocutaneous candidiasis: requirement for donor reactivity to candida antigen. (1978) (22)
Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors. (1981) (21)
Detection of human auto-anti-idiotypic antibodies (Ab2). I. Isolation and characterization of Ab2 in the serum of a ragweed immunotherapy-treated patient. (1988) (21)
Regulation of MIF by a factor in human serum. (1975) (20)
Detection of human auto-anti-idiotypic antibodies (Ab2). II. Generation of Ab2 in atopic patients undergoing allergen immunotherapy. (1988) (18)
Cellular sensitivity to collagen in rheumatoid arthritis. (1978) (17)
Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2). (1985) (17)
Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis. (1978) (17)
Lack of suppression of lymphocyte MIF production by estradiol, progesterone and human chorionic gonadotropin. (1980) (16)
Human cells required for macrophage migration inhibitory factor (MIF) production. (1977) (16)
IMMUNOLOGICAL IDENTIFICATION OF SUBPOPULATIONS OF MONONUCLEAR CELLS IN SARCOID GRANULOMAS * (1976) (15)
Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine. (1986) (15)
Histamine activates suppressor cellsin vitro using a coculture technique (2004) (15)
Mediators of cellular immunity, their nature and assay. (1976) (14)
Human leukocyte inhibitory factor (LIF): two distinct molecular species. (1979) (14)
Abnormal regulation of in vitro IgE synthesis by T cells obtained from patients with atopic dermatitis. (1985) (14)
Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components. (1976) (14)
Reduced prostaglandin E2 (PGE2) receptors on atopic T lymphocytes. (1986) (14)
Effects of leukocyte inhibitory factor (LIF) on neutrophil phagocytosis and bactericidal activity. (1987) (14)
Products of Activated Lymphocytes (1976) (14)
Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxis. (1985) (14)
METHOD FOR THE PRODUCTION OF MIF BY HUMAN BLOOD LYMPHOCYTES (1971) (14)
Histamine and immune modulation. (1983) (13)
Clinical applications of in vitro lymphocyte tests. (1974) (13)
Adult severe combined immunodeficiency and sarcoid‐like granulomas with hypersplenism (1978) (13)
Human lymphocyte-eosinophil interactions. I. Modulation of phytohemagglutinin-induced lymphocyte proliferation by eosinophils. (1985) (12)
Cellular hypersensitivity in Guillain-Barré syndrome. (1974) (12)
Dysregulation of arachidonic acid release and metabolism by atopic mononuclear cells (1989) (12)
Effect of dexamethasone on de novo IgE synthesis by human blood lymphocytes. (1985) (12)
Pharmacologic modulation in vitro of human histamine-induced suppressor cell activity. (1984) (12)
Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity. (1978) (12)
Immunologic responses during allergen-specific immunotherapy for respiratory allergy. (1988) (11)
Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes. (1982) (11)
The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages. (1980) (11)
Immune mechanisms in allergen-specific immunotherapy. (1989) (11)
Increased blastogenic responses to worm antigen and loss of adherent suppressor cell activity after treatment for human infection with Schistosoma mansoni. (1985) (11)
Inhibition of macrophage migration. (1971) (10)
Purification of a lymphoid cell line product with leukocyte inhibitory factor activity. (1982) (10)
Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma (2006) (10)
Plasma, red cell and white cell phospholipid essential fatty acids in atopic subjects with respiratory symptoms (1986) (9)
Leukocyte inhibitory factor stimulates neutrophil-endothelial cell adhesion. (1988) (9)
Glucocorticoid-induced enhancement of IgE synthesis. (1987) (9)
Effects of leukocyte inhibitory factor (LIF) on neutrophil mediated antibody-dependent cellular cytotoxicity. (1987) (8)
Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties. (1978) (8)
Corticosteroid allergy in a patient with systemic lupus erythematosus. (1974) (8)
Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity. (1981) (7)
In vitro anti-mitochondrial antibody synthesis in patients with primary biliary cirrhosis. (1986) (7)
Activated human eosinophils synthesize new proteins. (1987) (7)
Pneumocystis carinii and cytomegalovirus pneumonia in a previously healthy adult. (1982) (7)
Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810). (1984) (7)
Alterations of polymorphonuclear leukocyte surface charge by stimulated lymphocyte supernatants. (1980) (7)
Use of transfer factor in patients with depressed cellular immunity and chronic infection. (1975) (6)
Low incidence of systemic reactions during venom immunotherapy (1982) (6)
Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides. (1981) (6)
Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase. (1979) (6)
Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF). (1980) (5)
The effect of purified alpha-fetoprotein on in vitro assays of cell-mediated immunity. (1977) (5)
Induction of IgE synthesis in anti-IgM-activated nonatopic human B cells by recombinant interleukin-3. (1989) (5)
Macrophage migration inhibition test. (1970) (5)
Effects of leukocyte inhibitory factor (LIF) on human neutrophil function (1983) (5)
Reproductive immunology. (1987) (4)
Enhancement of the function of neutrophil type-1 and type-3 complement receptors by human leukocyte inhibitory factor (LIF). (1988) (4)
Humoral and cellular components in inflammation hyper‐reactivity and decreased feed‐back inhibition of asthmatic neutrophils (1988) (4)
Histamine and H2 antagonists in inflammation and immunodeficiency (1990) (4)
Inhibition of neutrophil superoxide production by fanetizole (1985) (4)
Mediators associated with delayed hypersensitivity. (1971) (4)
Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma (2007) (4)
54. Histamine-induced suppressor factor (HSF): Nature of stimulus and effect (1978) (3)
COMBINATION TRANSFER FACTOR-AMPHOTERICIN B THERAPY IN A CASE OF CHRONIC MUCOCUTANEOUS CANDIDIASIS: A CONTROLLED STUDY (1976) (3)
Anti-ragweed-specific anti-idiotypic antibodies in nonatopic and atopic subjects. (1985) (3)
Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes. (1975) (3)
219 Regulation of spontaneous in vitro IgE synthesis by autologous eczema and allogeneic nonatopic T cell subsets (1983) (2)
Role of histamine as a modulator of cellular-immune function. (1979) (2)
Reply to V Herbert (1991) (2)
Comparison of prostaglandins E2 and D2 as inhibitors of respiratory burst in neutrophils from atopic and nonatopic subjects (1988) (2)
Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes. (1972) (2)
A complicated case of penicillin allergy. (1984) (2)
In vitro cellular responses to ragweed antigen E(Ag E) (1973) (2)
Modulation of T and B Cell function by a histamine-induced lymphokine (1983) (2)
292 Asthmatic patients have “Activated” neutrophils that exhibit diminished responsiveness to adenosine (1988) (1)
Lymphocyte responses to ragweed antigens from different sources. (1979) (1)
Potentiation of neutrophil aggregation by human leukocyte inhibitory factor (1988) (1)
Chapter 29. Delayed Hypersensitivity: Its Mediation Through Products of Activated Lymphocytes (1973) (1)
T- and B-cell-derived supernatant factors enhance IgE synthesis by a myeloma cell line (U-266). (1988) (1)
Regarding the article by Guerra et al (1987) (1)
The chemotactic response of polymyxin-induced guinea pig eosinophils (1980) (1)
262 Human leukocyte inhibitory factor (LIF) modulates neutrophil (PMN) adherence to human endothelial cells (EC) (1988) (1)
MEDIATOR PRODUCTION BY HUMAN T AND B LYMPHOCYTES (2003) (1)
Lymphokines That Affect the Migration of Polymorphonuclear Leukocytes (1981) (1)
Functional heterogeneity of human splenic lymphocytes (1973) (1)
Physiological studies with human leukocyte inhibitory factor (1985) (1)
Studies on the detection of cellular immunity to human tumors by inhibition of macrophage migration. (1973) (1)
VITAMIN E SUPPLEMENTATION OF ELDERLY PEOPLE. AUTHORS' REPLY (1991) (0)
Cell-Mediated Immune Response of Ragweed-Sensitive Patients to Ragweed Antigen E IN VITRO LYMPHOCYTE TRANSFORMATION AND ELABORATIONOF LYMPHOCYTE MEDIATORS (0)
Role of calcium in the activation of neutrophils by leukocyte inhibitory factor (LIF). (1987) (0)
Physiological studies with human leukocyte inhibitory factor. (1985) (0)
19 Leukocyte inhibitory factor(LIF) potentiation of f-met-leu-phe induced chemotaxis and superoxide (O2−) generation (1985) (0)
22 Histamine type 1(H1) receptor radioligand binding studies in T cells from normal and atopic subjects (1985) (0)
The effect of histamine on in vitro macrophage inhibitory factor (MIF) production (1976) (0)
Methods for the treatment of atopic dermatitis by administration of an IL-4R antagonist (2013) (0)
Histamine-induced immunoregulation in atopic patients (1986) (0)
136 Generation of suppressor cells thai modulate IgE synthesis in atopic patients during immunotherapy (1985) (0)
Augmented cellular and humoral immune responses in mice depleted in vivo of de novo synthesized histamine (1986) (0)
De novo in vitro IgE synthesis by mononuclear cells (MNC) from atopic but not non-atopic subjects (1982) (0)
T Cell Regulation of IgE Synthesis in Atopic Patients (1983) (0)
Penicillin reactions. Desensitize or discontinue? (1986) (0)
541 Induction of IgE synthesis in normal human B cells by anti-IgM and T cell culture supernatant factor(s) (1988) (0)
Sustained B-lymphocyte immunodeficiency attributed to phenytoin therapy. (1987) (0)
Pernicious anemia, concordant twins, and immune dysfunction (1971) (0)
Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma (2013) (0)
Decreased sensitivity of atopic mononuclear cells to autacoids (1987) (0)
Purification of leukocyte inhibitory factor derived from a human non-T, Non-B cell line☆☆☆ (1982) (0)
Lymphokines that mediate inflammation (1984) (0)
Physicochemical characterization and pharmacologic modulation of the synthesis and/or secretion of histamine-induced suppressor factor (HSF). (1983) (0)
Lymphokines: mediators of delayed hypersensitivity. (1981) (0)
JUVENILE RHEUMATOID ARTHRITIS CELLULAR HYPERSENSITIVITY AND SELECTIVEIgADEFICIENCY (1972) (0)
Gender Differences in Postprandial Endothelial Function (2001) (0)
Immune mechanisms in allergy desensitization. (1982) (0)
98 Effect of dexamethasone (DM) on de novo IgE synthesis by human blood mononuclear cells (MNC) (1983) (0)
Regulatory control of migration inhibitory factor (1975) (0)
MATERNAL-FETAL RELATIONSHIP (1979) (0)
Lymphocyte Mediators That Modulate the Behavior of Macrophages (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ross E. Rocklin?

Ross E. Rocklin is affiliated with the following schools:

Tufts University